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Genome-Wide Association Studies
Nan M. Laird and Christoph Lange
Abstract. Genome-Wide Association Studies (GWAS) offer an excit-
ing and promising new research avenue for finding genes for complex
diseases. Traditional case-control and cohort studies offer many advan-
tages for such designs. Family-based association designs have long been
attractive for their robustness properties, but robustness can mean a
loss of power. In this paper we discuss some of the special features of
family designs and their relevance in the era of GWAS.
Key words and phrases: Genetic association, TDT, FBAT, PBAT,
two-stage designs.
1. INTRODUCTION
The potential of genome-wide association studies
(GWAS) to enable an unbiased search for disease
loci across the entire human genome provides us
with an unprecedented research opportunity in ge-
netics. Interrogating several hundred thousand SNPs
across many subjects at the same time raises many
statistical challenges in the design and analysis of
these studies. Genotyping on such a scale requires
new methodology for handling data quality issues;
likewise, association tests are computed for hundreds
of thousands of markers, whose results have to be
adjusted for multiple comparisons. The magnitude
of these problems raises the question of whether the
new technical ability to genotype such dense SNP
sets will translate into the identification of novel ge-
netic disease loci or whether the technical advance
remains under-utilized.
A popular way to address the multiple testing in
genome-wide association studies has been to design
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studies with a sample size of several thousand sub-
jects that are large enough that realistic effect sizes
can be detected, assuming that the test results will
be corrected for multiple testing using the Bonfer-
roni approach. However, such large studies come at a
price. By putting together samples of several thou-
sand subjects, phenotypic and genetic heterogene-
ity will be encountered in the sample. Further, since
the need for large sample sizes also influences the
study-design choice, the most commonly used design
choice is a case-control sample of unrelated individ-
uals with minimal or no covariates. Another popular
approach is a population-based design of unrelated
individuals without ascertainment condition related
to the outcome of interest (e.g., studying obesity in
a general population sample). In any event, the as-
certainment of subjects and collection of their phe-
notypic data is rarely carried out specifically for the
GWAS; rather, the expense of the genotyping has
led investigators to rely on samples previously col-
lected and phenotyped for other studies, in some
cases, large family samples that have been previ-
ously collected for other genetic studies. Although
the cost of genotyping is dropping rapidly, the cost
of genotyping still tends to drive study design and
make power considerations very crucial in the de-
sign.
An alternative approach to population-based or
case-control studies of unrelated individuals is family-
based studies. Family-based studies were used in
association studies originally to provide protection
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against spurious association arising with population
substructure. Family designs offer some unique ad-
vantages at the design and analysis phase of a GWAS.
Their complete robustness against heterogeneity
at a phenotypic and genetic level allows the joint
analysis of arbitrarily large and diverse samples with
family designs, an advantage in the GWAS setting.
As we will discuss in Section 3, they have both draw-
backs and benefits over conventional designs when
genotyping errors are present. We will also discuss
two-stage test strategies for family designs that main-
tain the original robustness of the approach, while
achieving power-levels that are similar to those of
population-based studies.
Our objective in this paper is to first describe
some of the special features of family-based designs
that make them attractive for association studies,
then focus particularly on their use in GWAS’s with
regard to genotyping errors and potential for ad-
dressing the multiple comparison problem.
2. OVERVIEW OF FAMILY DESIGNS FOR A
SINGLE MARKER
It has long been recognized that various sorts of
population substructure can distort tests of associ-
ation because different populations may have differ-
ent disease rates, and/or genotype frequencies
(Devlin and Roeder (1999); Pritchard, Stephens and
Donnelly (2000); Whittemore (2006)). Family de-
signs for genetic association studies were originally
suggested (Falk and Rubinstein (1987); Ott (1989);
Spielman, McGinnis and Ewens (1993)) as a way of
avoiding spurious association due to population sub-
structure. The classic paper by Speilman, McGin-
nis and Ewens (1993) on the Transmission Disequi-
librium Test (TDT) has contributed much to their
general popularity. There are many variations on
the family design, but the simplest and generally
most powerful design consists of selecting affected
offspring and their parents, and genotyping the trio.
Fig. 1. Trio design.
Essentially, having the genotypes of the parents en-
ables one to take advantage of “Mendelian Random-
ization” to avoid the need for an explicit control
group. Under the null hypothesis of no association
between the disease and the marker, each parent
transmits one of their two alleles to each offspring, at
random with probability 50/50 and independently
of the other parent and of any other offspring. For
the example in Figure 1, the mother can only trans-
mit the A allele, but the father can transmit either
A or B with probability 50/50. This holds when-
ever there is no selection of the offspring related
to the marker in question. Thus, when the parent’s
genotypes are known, one can easily calculate the
distribution of the offspring genotypes under H0.
This distribution is used to construct tests of the
null hypothesis. The observed and expected counts
can be used to construct an asymptotic χ2 test (Ott
(1989); Spielman, McGinnis and Ewens (1993)) or
exact tests can be used (Lazzeroni and Lange (1993)).
Because parents transmit independently to different
offspring, multiple affected siblings can be used, re-
sulting in a potential savings in genotyping costs.
With more common diseases, using transmissions to
unaffected siblings may also be beneficial
(Lange and Laird (2002)).
A Class of Score Tests for Family Designs
A more precise statistical argument regarding the
robustness of the family designs can be made by
considering the basis for the TDT test. The sim-
ple TDT test is a score test, based on the likeli-
hood of the offspring genotypes, conditioned on the
offspring trait and the parental genotypes (Schaid
(1996)). To develop this likelihood in a general set-
ting, let P denote the parental genotypes of a trio,
Y denote the trait of the offspring (here the trait
can be arbitrary), and let X denote some numeri-
cal coding for the offspring genotype, for example,
number of A alleles or a dummy variable coding for
a recessive or dominant genetic model. Further, let
f(Y |X,P, θ) denote the probability density of the
offspring trait, conditioned on the offspring geno-
type, the parental genotype and a vector of unknown
parameters, θ. In genetic terminology, f(Y |X,P, θ)
is the penetrance function and specifies the genetic
disease model. Generally, f(Y |X,P, θ) is assumed
not to depend directly on the parental genotypes
when offspring genotypes are in the model, but we
leave them in for generality. The vector θ will con-
tain both association parameters, say, β, and nui-
sance parameters, say, α, which will describe other
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aspects of the trait distribution. In particular, we
parameterize so that f(Y |X,P, θ) = f(Y |Xβ,P,α),
and under the null, β = 0, so that f(Y |X,P,β =
0, α) = f(Y |P,α), that is, the distribution of the
trait does not depend on the marker genotypes of
the offspring under the null. Further, let f(X|P )
be the probability density of the offspring genotype
conditioned on parental genotype. Note that the lat-
ter is completely known and determined by Mendel’s
laws, whereas the former reflects our alternative hy-
pothesis, and is generally unknown.
The conditional likelihood for the offspring geno-
type (X) given parental genotypes (P ) and the off-
spring trait (Y ) is given by
f(X|Y,P, θ) = f(Y |X,P, θ)f(X|P )
(1)
/
∑
f(Y |X,P, θ)f(X|P ),
where summation is over all X compatible with P .
An important feature of conditioning on P is that
any nuisance parameters in the distribution of the
parental genotypes, such as allele frequencies and
random mating assumptions, are not needed. As
noted above, the penetrance function does not de-
pend on X under the null, and hence cancels out of
the likelihood. Thus, the distribution of X under the
null is given simply by f(X|P ), which is completely
determined by Mendel’s laws; no assumptions need
be made about the distribution of parental geno-
types or about the phenotypes. Thus, a score test
will have the correctly specified null distribution as
long as Mendel’s laws hold, and will be completely
robust to not only population substructure, but to
potential misspecification of the trait distribution as
well.
In the TDT, we condition on Y = 1 and let X
denote the number of a particular allele that an in-
dividual has. The model p(Y = 1|X,P, θ) can take
any form, logistic, log-linear, linear, etc., with α
modeling the probability for X = 0. A simple form
for the penetrance function, which provides a gen-
eralization of the TDT for any phenotype, can be
obtained by assuming an exponential family model
for the trait distribution with a generalized linear
model for the mean response (Lunetta et al. (2000);
Liu et al. (2002); Dudbridge (2008)). In this case,
the score takes the special form of a type of covari-
ance between the trait and the marker:
U =
∑
[(Y −E(Y ))][X −E(X|P )],(2)
where summation is over all trios. Here E(Y ) is
the mean trait under H0 and may depend upon
the unknown nuisance parameters α, and E(X|P )
is computed using only Mendel’s laws. An asymp-
totic Z (or χ2) test statistic is formed by normalizing
(2) by the square root of
∑
(Y −E(Y ))2 var(X|P ),
where var(X|P ) can also be computed simply from
Mendel’s Laws. Alternately, exact tests using
Mendel’s laws to compute f(X|P ) can be easily
calculated (Lazzeroni and Lange (1993) and
Schneiter, Laird and Corcoran (2005)).
A potential barrier to constructing score tests in
this general case is in estimating the nuisance pa-
rameters α. Standard likelihood ratio methods can-
not be used here, because under the null, the like-
lihood does not depend on θ and the α parameters
cannot be estimated. The case of trios, where all
offspring are affected (Y = 1), is special in this re-
gard. Here, Y −E(Y ) is constant for everyone, and
because we condition on Y , the score test can be
reformulated as
U =
∑
[X −E(X|P )].(3)
It is easily seen that this score test yields the TDT
when X is coded to count the number of alleles of
interest (Schaid (1996)).
If we include unaffected offspring (Y = 0) as well
as affected, then equation (2) still holds, but the test
now depends upon estimating the prevalence E(Y )
because (Y −E(Y )) is not constant. If selection of
subjects depends upon disease status, then preva-
lence cannot be estimated from the sample data,
but often some a priori information is available. In
the more general case of measured phenotypes, the
test depends on the specified disease model via the
nuisance parameters implicit in E(Y ) and remains
valid regardless of choice of disease model provided
Mendel’s laws hold. While model choice can affect
power (Lange and Laird (2002); Lange, DeMeo and
Laird (2002)), choice of the wrong disease model
does not affect robustness, as the test is conditioned
on the trait. When samples are selected on the ba-
sis of the disease trait, as is generally the case with
dichotomous traits, the nuisance parameters cannot
be estimated from the data; methods for specifying
E(Y ) have been suggested (Lunetta et al. (2000);
Lange and Laird (2002); Lu and Cantor (2007);
Dudbridge (2008)).
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Missing Parental Information
Missing parental genotype information is a com-
mon problem, especially for later onset diseases.
There have been several approaches suggested for
handling missing parents, including estimating a
model for the parental genotypes distribution, and
using joint likelihood ratio tests (Weinberg (1999))
or using score tests which average over the estimated
distribution of the parental genotypes (Clayton
(1999)) for families with missing parents. These ap-
proaches are not guaranteed to retain robustness to
population substructure, especially since both ap-
proaches generally make simplifying assumptions con-
cerning the distribution of the parental genotypes
(e.g., common allele frequencies and Hardy–Weinberg
equilibrium); see Dudbridge (2008). Alternatively,
when siblings are sampled, f(X|P ) can be replaced
in the above equations by f(X|S), where S denotes
the sufficient statistic for parental genotype
(Rabinowitz and Laird (2000)). Being the sufficient
statistic, f(X|S) again does not depend upon
a model for parents’ genotype distribution, and the
score test remains fully robust. The distributions
are simple to enumerate, and tests based on (1)–(2)
with f(X|P ) replaced by f(X|S) if parents are not
available can be implemented in the FBAT
www.biostat.harvard.edu/˜fbat/ or PBAT www.
biostat.harvard.edu/˜clange software packages. How-
ever, the power of these tests can be much reduced,
depending upon the number of additional siblings
available. We refer to the FBAT test to describe this
general class of score tests which extends the TDT
to other traits and other family designs.
In summary, conditioning on both the parental
genotypes and the offspring traits ensures robust-
ness against misspecification of the disease model,
and to the distribution of offspring genotypes under
the null. The general approach has been extended
to handle multiple siblings (Lange and Laird (2002)
and Lange, DeMeo and Laird (2002)), missing par-
ents (Rabinowitz and Laird (2000)), multiple traits
(Lange et al. (2003)), haplotypes (Horvath et al.
(2004)) and multiple markers (Xu et al. (2006);
Rakovski et al. (2007)).
Comparative Power Issues: Single Marker Case
By and large, most approaches for analyzing
GWAS studies, conventional or family designs, begin
by testing each marker separately, and then do an
adjustment for multiple comparisons to determine
genome-wide significance and/or select promising
SNPs or regions for further study based on rankings
of some sort. There have been several proposals for
alternative methods of testing to increase power in
the face of multiple testing, as we will discuss in Sec-
tion 5, but, by-and-large, the genome-wide power of
a GWAS is usually estimated by calculating power
for a single marker, using some appropriate alpha-
level to adjust for multiple comparisons; thus, com-
parative power issues for single markers translate
directly to power calculations for genome-wide stud-
ies.
We note that this one-marker, one-test approach
is in strong contrast to genome-wide linkage scans,
where one can at least approximate the null distri-
bution of the test statistic across the genome, for ex-
ample, maximized lod-score, under the null hypoth-
esis of no linkage (Feingold, Brown and Siegmund
(1993)). With dense association scans, the unknown
pattern of LD precludes specification of the joint
distribution of the association test statistics under
the null of no association. In principle, using per-
mutation tests in case-control studies can consider-
ably improve the probability of at least one posi-
tive finding, but the magnitude of the computations
are prohibitive in a GWAS with hundreds of thou-
sands of SNPs. An exception to the one test per
typed SNP are methods which incorporate informa-
tion from the Hapmap to impute non-typed SNPs,
gaining additional power via testing a denser marker
set (Marchini et al. (2007)). Thus far, this approach
has been limited to case-control data and investiga-
tion of methodology for family designs is desirable.
Family-based tests, being conditional tests, are ro-
bust and essentially model free, but the price of such
robustness is some cost in terms of power. There are
some cases, and some designs, however, where the
power is essentially equivalent, as was shown for rare
disease and the additive model in Laird and Lange
(2006). Here we consider power comparisons for the
recessive model with an α-level of 0.00001 to more
nearly reflect a GWAS testing situation. Figures 2
and 3 compare the power of four different designs:
case-control, trios, discordant sib pairs (DSP) and
discordant sib trios (DST; at least one discordant
sib pair and one other sibling), for a rare disease and
a common one. The odds ratio is 1.75 in both cases,
and the number of affected (1500) is the same for
each design, although number of genotypes required
can be different depending on design. The DSP de-
sign is always very inefficient, whereas DST can do
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Fig. 2. Power for a common disease: 14%.
well with more common disorders. For the recessive
model, the power of the case-control design and the
trio design are virtually identical for common dis-
eases (e.g., prevalence 14%), with minor advantages
for trio designs for low allele frequency and minor
advantages for the case-control design for common
alleles. However, for rare diseases, the trio design is
much for powerful than the case/control design. The
reason for the relative power loss of the case/control
design is that, for rare diseases, the differences be-
tween the genotype distribution of healthy controls
and the genotype distribution of the general popu-
lation are minimal and the contribution of the con-
trols to the power of the test statistic diminishes. For
the trio design, we use only cases and, consequently,
such designs do not suffer this relative power loss for
small prevalences. The power results for the trios dif-
fer slightly by prevalence because we base our model
on the odds ratio rather than the relative risk model.
We provide some simple algebraic calculations in the
Appendix to illustrate this point.
Fig. 3. Rare disease: 1%.
3. QUALITY CONTROL/DATA CLEANING IN
FAMILY DESIGNS
The large amount of genotyping required for a
GWAS is accomplished via specially designed geno-
typing platforms commonly called SNP-chips. Geno-
typing errors include several types of failures that
can occur in the genotyping process; these can re-
sult in either missingness and/or misclassification
of genotypes. The raw data of a single genotype
for a single individual is a pair of measured inten-
sities for each allele; the intensities are translated
into genotypes, generally using some type of statis-
tical clustering algorithm, referred to as the ‘geno-
type calling algorithm.’ Perhaps due to poor DNA
quality or design issues of the SNP-chip, the sample
may simply fail to provide intensities or the intensi-
ties do not separate into the three possible genotype
clusters, making it impossible to obtain called geno-
types. These errors all give rise to missing genotypes.
Further missingness arises in the data cleaning pro-
cess which is described below. Misclassification oc-
curs if the calling algorithm makes a genotype call
which is not correct; the probability for misclassify-
ing a genotype generally increases with lower minor
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allele frequencies, and can depend upon the true,
unobserved, genotype.
In the data cleaning step of a GWAS, basic sta-
tistical analysis tools are used as quality control fil-
ters to identify SNPs and probands for which the
SNP-chip is not able to provide sufficient genotyping
quality (Manolio et al. (2007)). Such analysis tech-
niques/filters include tests for departures from the
Hardy–Weinberg Equilibrium, removal of SNPs with
low frequencies or low “call rates,” or deletion of in-
dividuals with low call rates. Since the inclusion of
SNPs and probands with misclassified genotypes can
lead to a substantial reduction in power, the data
cleaning/filtering step is one of the most important
parts in the analysis of a GWAS. While there has
been much progress in improving genotype calling
and data cleaning algorithms, we can expect that
there will continue to be some level of missing and
misclassification in all GWAS’s.
When family data are used, an additional quality-
control filter that is applied in the data cleaning step
is the removal of Mendelian inconsistencies. Mendelian
inconsistencies are genotype configurations in fam-
ilies that violate Mendel’s Law. For example, if a
“B”-allele is observed in a subject whose parents
do not carry any “B”-alleles, this is an obvious vi-
olation of Mendel’s law. Such genotype configura-
tions are excluded from the analysis. Furthermore,
if Mendelian inconsistencies are more frequent for
certain markers or families, this suggests that there
are fundamental problems with the genotyping for
these markers/families and, it is common practice
to exclude them from the analysis altogether. Mark-
ers and/or families with more than five Mendelian
inconsistencies are generally removed from the anal-
ysis.
For population-based designs, the presence of geno-
typing errors resulting in either misclassification and
or missing genotypes does not cause bias under the
null provided errors/missingness is non-differential
in cases and controls. By non-differential, we mean
errors occur irrespective of case or control status.
Genotyping cases and controls separately can lead
to differential genotyping errors, and considerable
bias in association tests. With non-differential geno-
typing errors, there is no bias under the null and the
effect of the genotyping error is to simply decrease
the overall power of the GWAS for the population
design.
For family-based designs, the effects of genotyp-
ing errors are different. It is a well described phe-
nomenon in the literature (Gordon et al. (2001),
2002; Douglas, Skol and Boehnke (2002); Sobel,
Papp and Lange (2002); Kang, Gordon and Finch
(2004)) that genotyping errors can cause biased tests
with inflated significance levels. With families, it
will be possible to identify some of the misclassi-
fied genotypes by verifying that the offspring’s geno-
type is not plausible based on the parental geno-
types (or in some cases, sibling genotypes). However,
by removing families with transmission inconsisten-
cies from the association analysis, only a fraction
of the genotyping error is eliminated from the anal-
ysis. In the computation of the test statistic, this
causes a seeming over-transmission of the major al-
lele, which leads to the anti-conservativeness of the
family-based association test.
Thus, while population-based studies have reduced
power in the presence of genotyping errors, family-
based studies will, in addition to that, have inflated
pre-specified significance levels. To judge the rela-
tive importance of this fundamental difference be-
tween the two study-design types, it is important to
consider the main purpose of GWA studies. Their
goal is the discovery of new genetic disease loci and
their confirmation/replication in independent stud-
ies/samples. This is typically achieved by selecting
the markers with the smallest p-values from the GWA
and trying to confirm/replicate them in independent
studies. It is obvious that the presence of genotyp-
ing errors will reduce the overall power of both de-
sign types, either because of reduced power (case-
control) or by both reduced power and inflated type-
1 error (family designs). However, it is unclear for
which design type these effects are more deleterious
and careful simulation studies are much needed to
address this issue.
In practice, it will be important to estimate the
undetected genotyping error rate in the data in or-
der to assess the reduction in overall-power of the
GWA study that is attributable to this error source.
Otherwise, if a GWA is unable to identify new loci,
it is unclear whether this is due the actual absence
of genetic risk loci or due to the reduction in overall
power caused by poor genotyping quality. Family-
based studies offer a unique possibility to estimate
the undetected genotyping error rate. By looking at
the transmission pattern of the common allele for
all genotyped markers in a GWA study, an overall/
genome-wide FBAT statistic can be computed and
the undetected genotyping error rate in the study
can be estimated through simulations under various
error models (Fardo, Ionita and Lange (2008)).
FAMILY DESIGNS IN GWAS 7
4. TESTING STRATEGIES FOR THE
MULTIPLE COMPARISON PROBLEM IN
GENOME-WIDE ASSOCIATION STUDIES
With mapping arrays for more than one million
SNPs now available (Matsuzaki et al. (2004);
Di et al. (2005); Gunderson et al. (2006); Wadma
(2006)), genome-wide association studies carry the
promise to identify replicable associations between
important genetic risk factors and most complex dis-
eases. One of the major hurdles that needs to be
addressed in order to make genome-wide associa-
tion studies successful is the multiple comparison
problem. Hundreds of thousands of SNPs are geno-
typed and examined for potential associations with
multiple phenotypes, possibly using different model
assumptions, resulting in potentially millions of sta-
tistical tests.
Initial efforts to resolve this problem with case-
control designs were directed toward multi-stage de-
signs involving multiple independent samples. At
stage 1, all SNPs are tested in a relatively small sam-
ple and the most significant ones retained for test-
ing with a larger, independent sample; the winnow-
ing process can be repeated multiple times. How-
ever, Skol et al. (2006) showed that such designs are
inherently less powerful than designs which use all
samples for the final analysis of selected SNPs, even
though Bonferroni adjustment must be made for
testing all SNPs. Thus, the desired strategy now for
population based designs is to select a large enough
sample (3–5000 cases and an equal number of con-
trols) to achieve sufficient power for all SNPs simul-
taneously, but also utilize independent “replication”
samples which are different from the original sample
in some distinct way, for example, non-overlapping
populations.
Other strategies to ameliorate the multiple com-
parisons problem utilize some “outside” informa-
tion, for example, information from linkage stud-
ies, functional SNPs, etc. Such approaches include
Bayesian approaches which use prior distributions
to specify effects for markers (Wakefield (2008)),
weighted Bonferroni methods which assign different
significance levels to each SNP according to their
“importance or relevance” (Roeder, Devlin and
Wasserman (2007); Eskin (2008)) and split-sample
approaches (Wasserman and Roeder (2006);
Song et al. (2007)). For family-based association
tests, the idea of using “outside information” natu-
rally translates to the use of the information about
the association at a population-based level that is
not utilized in the family-based association test.
A general approach to two-stage testing for fam-
ily designs builds on the two information sources
about association that are present in family-based
designs. Using the notation introduced in Section 2
for the distribution of X and Y , the joint distribu-
tion for X , Y and P (or, equivalently, S) can be
partitioned into two statistically independent com-
ponents (Laird and Lange (2006)),
f(X,Y,P |Φ, θ) = f(X|Y,P, θ)f(Y,P |Φ, θ),(4)
where Φ represents additional parameters required
to model the parental genotype distribution, for ex-
ample, genotype frequencies and possible non-random
mating. Note that both components, f(X|Y,P, θ)
and f(Y,P |Φ, θ) will have information about θ, but
the information from f(Y,P |Φ, θ), will depend on
the parental genotype distribution, and can be sen-
sitive to population substructure.
For the first step of the testing strategy, the screen-
ing step, we use the information in f(Y,P |Φ, θ), to
estimate the association parameters; the second, or
testing step, uses f(X|Y,P,Φ, θ). The likelihood de-
composition implies that both steps of the testing
strategy are independent. The “evidence for associ-
ation” estimated from f(Y,P |Φ, θ) can be utilized in
the testing stage, without having to adjust the test
for the estimation of the genetic effect size in the
first stage. Several methods have been suggested to
exploit this relationship in developing testing strate-
gies which use both forms of information in order
to increase power, while retaining robustness of the
test.
Van Steen et al. (2005a) originally proposed a ver-
sion of this two-step testing strategy for the analy-
sis of quantitative traits. First, an effect size is es-
timated for each SNP by regressing the offspring
phenotype Y on E(X|P ); this effect size is used to
calculate the estimated power of the FBAT statistic
for each SNP (Lange and Laird (2002)). Some num-
ber of top ranking SNPs (10 or 20) were selected
for testing with the FBAT statistic at the second
stage. Because of the independence, both steps can
be applied to the same data set without having to
adjust the overall significance level for the multiple
usage of the data. An extension by Ionita-Laza et al.
(2007) proposed testing all SNPs at the second stage
using weighted Bonferroni. Extensions of this test-
ing strategy are available for using parental pheno-
types and arbitrary structures at the screening stage
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(Feng, Zhang and Sha (2007)) and for case/control
designs (Zheng et al. (2007)).
The Van Steen approach has three key advan-
tages: (1) The method achieves statistical power lev-
els which can be substantially higher than those
of standard family-based approaches and is thereby
able to establish genome-wide significance with
smaller/more realistic sample sizes (Van Steen et al.
(2005b); Ionita-Laza et al. (2007); Feng, Zhang and
Sha (2007); Zheng et al. (2007)). (2) The Van Steen
algorithm maintains the separation between the mul-
tiple testing problem and the replication process.
Replication attempts in different studies are reserved
for the generalization of the established associations
and the assessment of heterogeneity between study
populations. (3) Since genome-wide significance is
established in the first data set, the number of SNPs
that is pushed forward to true replication in other
populations is generally very small and does not
require a large budget, which makes simultaneous
replication attempts in multiple samples feasible.
Extensive simulation studies have shown that 2-stage
testing strategies that utilize both sources of infor-
mation about the association can help family-based
studies to achieve power levels that are similar to
those of population-based studies, while maintain-
ing the original advantages of family-based study,
that is, complete robustness against confounding.
By looking at the distribution of parental mating
types in ascertained samples f(P |Y,Φ, θ), Murphy
et al. (2008) extended the general approach to the
trio-designs in which all probands are affected (Y =
1). Even here, the application of 2-stage Van Steen-
testing strategies can lead to meaningful power im-
provements over the standard TDT. Other possibil-
ities for utilizing the information from the screen-
ing step include specifying “tuning-parameters” in
the FBAT-statistic (Lange et al. (2004); Jiang et al.
(2006)) so that the power of the FBAT test is max-
imized.
5. DISCUSSION
Family designs have historically been popular be-
cause of their robustness to population substruc-
ture. An additional, often unappreciated, feature of
family-designs which is important with measured or
time-to-onset outcomes is their robustness to model
specification, and the ability to utilize the popula-
tion information to specific unknown parameters in
the model. With the availability of modern SNP
chips, and genotyping of thousands of subjects on
hundreds of thousands of markers, we now have the
potential to identify the genetic backgrounds of in-
dividuals, and utilize that information to control
for confounding by population substructure in case-
control studies (Roeder and Luca (2008)). An im-
portant question is whether or not there is a need
for family designs in the era of GWAS, given the
potential to resolve difficulties with population sub-
structure in case control designs. Additional stud-
ies and experience with actual studies are needed
to compare the performance of family designs and
adjusted case-control designs in GWAS settings.
Hampered by limitations in terms of power in many
scenarios, and by the difficulty of recruitment, family-
based designs certainly cannot be considered as the
gold standard approach in genome-wide association
studies. However, given the unique properties and
features of a family design, they will continue to
play a pivotal role in large scale association studies.
In multi-stage genome-wide association studies,
family-based studies should be utilized as one of the
stages as early as the budget permits its implemen-
tation. Their complete robustness against both ge-
netic confounding and misspecification of the phe-
notypic model provides them with an important role
in the process of replicating and validating findings
of the discovery step. Given the unavoidable genetic
and phenotypic heterogeneity in large-scale multi-
stage genome-wide association studies, this feature
of family-based association tests is crucial and should
not be ignored. If the budget permits the additional
genotyping cost, family-studies can be a favorable
choice for the first stage of a genome-wide associa-
tion study. There, family-based studies can be de-
signed so that they have equivalent power to
population-based studies and, at the same time, of-
fer a unique combination of additional analysis fea-
tures and robustness properties.
While the analysis features of family-based de-
signs make them an attractive choice in the design
phase of genome-wide studies, their abilities to as-
sess the magnitude of the hidden genotyping error
should always be utilized, even with case/control de-
signs. By genotyping a small number of families on
the same platform with the case/control samples,
researchers can examine the genotyping quality of
the data after the QC process and assess the true
power of the study.
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APPENDIX
Here we do some simple calculations which illus-
trate the power differences between case-control and
trio designs. The basic idea is to calculate the ex-
pected value of the corresponding Z statistics un-
der the alternative. To make the calculations sim-
ple, we use a relative risk model, and we assume
that allele frequency, the relative risk and preva-
lence are small. We use the following notation: p
= disease allele frequency, ρ = relative risk, K =
prevalence, r = P (Y = 1|X = 0), where Y = 1 in-
dicates disease, and X = 1 indicates the recessive
genotype. Assuming the Hardy–Weinberg Equilib-
rium holds in the population, P (X = 1) = p2 and
K = ρrp2 + r(1− p2)⇒ r=K/(ρp2 + (1− p2)).
For the case-control design, we compute
pcases = P (X = 1|Y = 1)
= rρp2/K and
(5)
pcontrols = P (X = 1|Y = 0)
= (1− rρ)p2/(1−K),
and letting p¯= (pcases−pcontrols)/2, we have that the
expected Z is approximately
E(Z) =
√
N(pcases − pcontrols)/
√
2p¯(1− p¯),(6)
where N is the number in each group. For N =
1500, p = 0.1, K = 0.01 and ρ = 1.75, this gives
pcases ≈ 0.0174, pcontrols ≈ 0.0099 and E(Z) ≈ 1.75,
which corresponds to the notion of zero power if
α= 0.00001.
For the trio design, we consider the 2 informa-
tive mating types, that is, 2 heterozygous parents
(Type 1) and one heterozygous parent and one rare
homozygous parent (Type 2). Under the alternative
hypothesis, the expected number of families for each
mating type can be calculated by
Type 1: rp2(1− p)2(ρ+3)N/K,
Type 2: 2rp3(1− p)(ρ+1)N/K.
Next, we compute the Mendelian residuals which
are defined as the expected marker score under the
alternative hypothesis minus the expected marker
score under the null-hypothesis for both mating types:
Type 1: 3(ρ− 1)/4(ρ+ 1),
Type 2: (ρ− 1)/2(ρ+1).
The variance of the mating-types used in the de-
nominators of the FBAT statistics are given by 3/16
and 1/4 respectively.
Then the expected FBAT-statistic for a recessive
model under the alternative hypothesis is given by
E(Z) =
2p(ρ− 1)
√
N(r/K)(1− p)(3 + ρ)√
ρ(p+ 3)− 5p+ 9 .(7)
For the parameters given above, this equals Z =
4.56, which results in the observed power levels of
the plot for K = 0.01.
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